Palomar Medical Technologies, Inc. 

(Public, NASDAQ:PMTI)   Watch this stock   
Find more results for PMTI
Oct 29, 2009
Q3 2009 Earnings Conference Call - Webcast
Oct 29, 2009
Q3 2009 Earnings Release
More events from AOL Finance »    

Key stats and ratios

Q3 (Sep '09) 2008
Net profit margin -2.04% -0.08%
Operating margin -3.79% -3.88%
EBITD margin - -3.08%
Return on average assets -0.69% -0.04%
Return on average equity -0.81% -0.05%
Employees 200 -

Address

82 Cambridge Street
Burlington, MA 01803
United States - Map
+1-781-9932300 (Phone)
+1-781-9932330 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Options - Morningstar
Research Reports - Yahoo Finance
Annual Report (PDF) - AnnualReports.com

Palomar Medical Technologies, Inc. discussed on blogs

Ranking 1100+ Micro Cap Stocks by Upside Potential - NASD100.com ... - Investor's Resources - NASD100.com - Daily Stock Rankings - Nov 20, 2009

Palomar Medical Technologies, Inc. discussions

  View all discussions »

Description

Palomar Medical Technologies, Inc. (Palomar), design, manufacture, market and sell lasers and other light-based products and related disposable items and accessories for use in medical and cosmetic procedures. The Company offers a comprehensive range of products based on technologies that include, but are not limited to: hair removal; body sculpting, including laser-assisted liposuction; removal of vascular lesions, such as rosacea, spider veins, port wine stains and hemangiomas; wrinkle reduction; removal of leg veins; removal of benign pigmented lesions, such as age and sun spots, freckles and melasma; tattoo removal; acne treatment; skin resurfacing, pseudofolliculitis barbae (PFB) treatment; treatment of red pigmentation in hypertrophic and keloid scars; treatment of verrucae, skin tags and seborrheic keratosis; skin tightening through soft tissue coagulation; scars, including acne scars, stretch marks and warts, soft tissue coagulation and other skin treatments.

Officers and directors

Louis P. Valente
Executive Chairman of the Board
Portrait. Age: 78
Bio & Compensation - Reuters
Joseph P. Caruso
President, Chief Executive Officer, Director
Age: 50
Bio & Compensation - Reuters
Paul S. Weiner
Chief Financial Officer, Treasurer
Portrait. Age: 45
Bio & Compensation - Reuters
Nicholas P. Economou Ph.D.
Director
Age: 60
Bio & Compensation - Reuters
James G. Martin Ph.D.
Director
Age: 73
Bio & Compensation - Reuters
A. Neil Pappalardo
Director
Age: 66
Bio & Compensation - Reuters
Jeanne Cohane
Director
Age: 62
Bio & Compensation - Reuters